Peri-operative haemoglobin: An overview of current opinion regarding the acceptable level of haemoglobin in the peri-operative period

European Journal of Anaesthesiology

Volumn 13, Issue 4, 1996, Pages 316-324

  Wedgwood, J J ^a   Thomas, J G ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIPHOSPHOGLYCERIC ACID; HEMOGLOBIN;

ANEMIA; BLEEDING; BLOOD FLOW; BLOOD TRANSFUSION; BLOOD VISCOSITY; HEART OUTPUT; HEMODILUTION; HUMAN; MORBIDITY; MORTALITY; OXYGEN CONSUMPTION; PERIOPERATIVE PERIOD; REVIEW; RISK; SYSTEMIC VASCULAR RESISTANCE; VENOUS RETURN;

EID: 0030035483     PISSN: 02650215     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003643-199607000-00003     Document Type: Review

References (58)

1. Clinical Resource and Audit Group (Chairman Jennett B.) Optimal Use Of Donor Blood. The Scottish Office 1995.
2. Sirchia G, Giovanetti AM, McClelland DBL, Fracchia GN. EUR 15398 - Safe and Good Use of Blood in Surgery (SANGUIS) - Use of Blood Products and Artificial Colloids in 43 European Hospitals.
3. Goodnough LT, Johnston MFM, Toy PTCY and the Transfusion Medicine Academic Award Group. The variability of transfusion practice in coronary artery bypass surgery. JAMA 1991; 265: 86-90.
4. Diethrich EB. Evaluation of Blood Transfusion Therapy. Transfusion 1965; 5: 82-88.
5. Reece RL, Beckett RS. Epidemiology of Single-Unit Transfusion. JAMA 1966; 195: 113-118.
6. Friedman BA. Patterns of blood utilization by physicians: transfusion of nonoperated anemic patients. Transfusion 1978; 18: 193-198.
7. Mozes B, Epstein M, Ben-Bassat I, Modan B, Halkin H. Evaluation of the appropriateness of blood and blood product transfusion using preset criteria. Transfusion 1989; 29: 473-476.
8. Nicholls MD, Whyte G. Red Cell, Plasma and Albumin Transfusion Decision Triggers. Anaesth and Intensive Care 1993; 21: 156-162.
9. Adams RC, Lundy JS. Anesthesia in cases of poor surgical risk. Surgery, Gynecology and Obstetrics 1942; 74: 1011-1019.
10. Welch HG, Meehan KR, Goodnough LT. Prudent Strategies for Elective Red Blood Cell Transfusion. Ann Intern Med 1992; 116: 393-402.
11. Consensus Conference. Perioperative Red Blood Cell Transfusion. JAMA 1988; 260: 2700-2703.
12. Rand PW, Lacombe E, Hunt HE, Austin WH. Viscosity of normal human blood under normothermic and hypothermic conditions. J Appl Physiol 1964; 19: 117-122.
13. Fowler NO, Holmes JC. Blood viscosity and cardiac output in acute experimental anemia. J Appl Physiol 1975; 39: 453-456.
14. Fan F-C, Chen RYZ, Schuessler GB, Chien S. Effects of hematocrit variations on regional hemodynamics and oxygen transport in the dog. Am J Physiol 1980; 238: H545-552.
15. Chapler CK, Cain SM. The physiologic reserve in oxygen carrying capacity: studies in experimental hemodilution. Can J Physiol Pharmacol 1986; 64: 7-12.
16. Guyton AC, Richardson TQ. Effect of Hematocrit on Venous Return. Circ Res 1961; 9: 157-164.
17. Messmer KFW. Acceptable Hematocrit Levels in Surgical Patients. World J Surg 1987; 11: 41-46.
18. Clarke TNS, Foex P, Roberts JG, Saner CA, Bennett MJ. Circulatory responses of the dog to acute isovolumic anaemia in the presence of high-grade adrenergic beta-receptor blockade. Br J Anaesth 1980; 52: 337-341.
19. Crystal GJ, Salem MR. Myocardial and systemic hemodynamics during isovolemic hemodilution alone and combined with nitroprusside-induced controlled hypotension. Anesth Analg 1991; 72: 227-237.
20. Hint H. The pharmacology of dextran and the physiological background for the clinical use of Rheomacrodex and Macrodex. Acta Anaesthesiol Belg 1968; 2: 119-138.
21. Lundsgaard-Hansen P. Hemoduution - new clothes for an anemic emperor. Vox Sanguinis 1979; 36: 321-336.
22. Messmer K, Sunder-Plassmann L, Klovekorn WP, Holper K. Circulatory significance of hemodilution: rheological changes and limitations. Advances in Microcirculation 1972; 4: 1-77.
23. Duruble M, Martin JL, Duvelleroy M. Effects theoretiques experimentaux et cliniques des variations de l'hematocrite au cours de l'hemodilution. Annales de Anesthesiologie Francaise 1979; 9: 805.
24. Van Woerkens ECSM, Trouwborst A, Van Lanschot JJB. Profound hemodilution: what is the critical level of hemodilution at which oxygen delivery-dependent oxygen consumption starts in an anesthetized human? Anesth Analg 1992; 75: 818-821.
25. Shibutani K, Komatsu T, Kubal K, Sanchala V, Kumar V, Bizzarri DV. Critical level of oxygen delivery in anesthetized man. Crit Care Med 1983; 11: 640-643.
26. Noldge GFE, Priebe H-J, Bohle W, Buttler KJ, Geiger K. Effects of acute normovolemic hemodilution on splanchnic oxygenation and on hepatic histology and metabolism in anesthetized pigs. Anesthesiology 1991; 74: 908-918.
27. Kettler D. 'Permissive anaemia' compared with blood transfusion in patients with cardiac disease: another point of view. Current Opinion in Anaesthesiology 1994; 7: 1-4.
28. 2 during recovery from anaesthesia. Br J Anaesth 1968; 40: 398-406.
29. Edwards AD, Richardson C, Van Der Zee P, et al. Measurement of hemoglobin flow and blood flow by near-infrared spectroscopy. J Appl Physiology 1993; 75: 1884-1889.
30. Carson JL, Spence RK, Poses RM, Bonavita G. Severity of anaemia and operative mortality and morbidity. Lancet 1988; 2: 727-729.
31. Spence RK, Carson JA, Poses R, et al. Elective surgery without transfusion: influence of preoperative hemoglobin level and blood loss on mortality. Am J Surg 1990; 159: 320-324.
32. Viele MK, Weiskopf RB. What can we learn about the need for transfusion from patients who refuse blood? The experience with Jehovah's Witnesses. Transfusion 1994; 34: 396-401.
33. Nelson AH, Fleisher LA, Rosenbaum SH. Relationship between postoperative anemia and cardiac morbidity in high-risk vascular patients in the intensive care unit. Crit Care Med 1993; 21: 860-866.
34. Christopherson R, Frank S, Norris E, Rock P, Gottlieb S, Beattie C. Low postoperative hematocrit is associated with cardiac ischemia in high-risk patients. Anesthesiology 1991; 75: A99.
35. Parsloe MRJ, Wyld R, Fox M, Reilly CS. Silent myocardial ischaemia in a patient with anaemia before operation. Br J Anaesth 1990; 64: 634-637.
36. Mangano DT, Browner WS, Hollenberg M, London MJ, Tubau JF, Tateo IM and the Study of Perioperative Ischaemia Research Group. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. N Engl J Med 1990; 323: 1781-1788.
37. Murphy WG, McClelland DBL. Deceptively low morbidity from failure to practice safe blood transfusion: an analysis of serious blood transfusion errors. Vox Sanguinis 1989; 57: 59-62.
38. McClelland DBL, Phillips P. Errors in blood transfusion in Britain: survey of hospital haematology departments. Br Med J 1994; 308: 1205-1206.
39. Nohr CW, Christou NV, Rode H, Gordon J, Meakins JL. In Vivo and In Vitro Humoral Immunity in Surgical Patients. Ann Surg 1984; 200: 373-380.
40. Hammer JH, Nielsen HJ, Moesgaard F, Kehlet H. Duration of postoperative immunosuppression assessed by repeated delayed type hypersensitivity skin tests. Eur Surg Res 1992; 24: 133-137.
41. Nielsen HJ, Hammer JH, Moesgaard F, Kehlet H. Comparison of the effects of SAG-M and whole blood transfusions on postoperative suppression of delayed hypersensitivity. Can J Surg 1991; 34: 146-150.
42. Perttila JT, Salo MS, Jalonen JR, Kuttila KT, Viinamaki O, Pulkki KJ. Blood transfusion with autologous and leukocyte-depleted or standard allogeneic red blood cells and the immune response to open heart surgery. Anesth Analg 1994; 79: 654-660.
43. Burrows L, Tartter P. Effect of blood transfusions on colonic malignancy recurrence rate. Lancet 1982; 2: 662.
44. Chung M, Steinmetz OK, Gordon PH. Perioperative blood transfusion and outcome after resection for colorectal carcinoma. Br J Surg 1993; 80: 427-432.
45. Tang R, Wang JY, Chien CRC, Chen JS, Lin SE, Fan HA. The Association between Perioperative Blood Transfusion and Survival of Patients with Colorectal Cancer. Cancer 1993; 72: 341-348.
46. Blumberg N, Chuang-Stein C, Heal JM. The relationship of blood transfusion, tumor staging, and cancer recurrence. Transfusion 1990; 30: 291-294.
47. Busch ORC, Hop WCJ, Hoynck van Papendrecht MAW, Marquet RL, Jeekel J. Blood transfusions and prognosis in colorectal cancer. N Engl J Med 1993; 328: 1372-1376.
48. Ford CD, VanMoorleghem G, Menlove RL. Blood transfusions and postoperative wound infection. Surgery 1993; 113: 603-607.
49. Triulzi DJ, Blumberg N, Heal JM. Association of transfusion with postoperative bacterial infection. Critical Reviews in Clinical Laboratory Sciences 1990; 28: 95-107.
50. Heiss MM, Mempel W, Jauch K-W, et al. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet 1993; 342: 1328-1333.
51. Miholic J, Hudec M, Domanig E, et al. Risk factors for severe bacterial infections after valve replacement and aortocoronary bypass operations: analysis of 246 cases by logistic regression. Annals of Thoracic Surgery 1985; 40: 224-228.
52. Von Doersten P, Cruz RM, Selby JV, Hilsinger RL. Transfusion, recurrence, and infection in head and neck cancer surgery. Otolaryngology - Head and Neck Surgery 1992; 106: 60-67.
53. Vamvakas EC, Moore SB. Blood transfusion and postoperative septic complications. Transfusion 1994; 34: 714-727.
54. Jatzko G, Lisborg P, Wette V. Improving survival rates for patients with colorectal cancer. Br J Surg 1992; 79: 588-591.
55. Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in non-cardiac surgical procedures. N Engl J Med 1977; 297: 845-850.
56. Audet A-M, Goodnough LT. Practice strategies for elective red blood cell transfusion. Ann Intern Med 1992; 116: 403-406.
57. Carson JL, Willett LR. Is a hemoglobin of 10 g dL required for surgery? Medical Clinics of North America 1993; 77: 335-347.
58. Grimshaw J, Russell I. Achieving health gain through clinical guidelines. Developing scientifically valid guidelines. Quality in Health Care 1993; 2: 243-248.